date:Jan 20, 2022
f Tnuva Group.
We expect the collaboration between the companies to revolutionize the cultured food industry and develop the next generation of alternative proteins, he explains.
The collaboration with Tnuva supports Pluristems strategy to establish partnerships that leverage its cell-based technology platform.
As we embark on this collaboration with Tnuva, Pluristem is still dedicated to its core business of developing cell therapy products, says Yaky Yanay, CEO and president of Pluristem